Singapore markets closed

Satellos Bioscience Inc. (0ITA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2780+0.0080 (+2.96%)
At close: 08:00AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 35.95M
Enterprise value 4.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.14
Enterprise value/revenue N/A
Enterprise value/EBITDA 4.44

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-12.58%
S&P500 52-week change 326.27%
52-week high 30.5200
52-week low 30.1680
50-day moving average 30.3232
200-day moving average 30.2897

Share statistics

Avg vol (3-month) 35
Avg vol (10-day) 3N/A
Shares outstanding 5112.79M
Implied shares outstanding 6129.32M
Float 888.52M
% held by insiders 112.45%
% held by institutions 16.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-38.28%
Return on equity (ttm)-72.15%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -15.46M
Net income avi to common (ttm)-15.89M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.59M
Total cash per share (mrq)0.35
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)11.13
Book value per share (mrq)0.36

Cash flow statement

Operating cash flow (ttm)-14.5M
Levered free cash flow (ttm)-7.25M